Stem cell delivery of therapies for brain disorders
Abstract The blood brain barrier (BBB) poses a problem to deliver drugs for brain malignancies and neurodegenerative disorders. Stem cells such as neural stem cells (NSCs) and mesenchymal stem cells (MSCs) can be used to delivery drugs or RNA to the brain. This use of methods to bypass the hurdles o...
Main Authors: | Alexander Aleynik, Kevin M Gernavage, Yasmine SH Mourad, Lauren S Sherman, Katherine Liu, Yuriy A Gubenko, Pranela Rameshwar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-12-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/2001-1326-3-24 |
Similar Items
-
Suicide gene therapy using allogeneic adipose tissue-derived mesenchymal stem cell gene delivery vehicles in recurrent glioblastoma multiforme: a first-in-human, dose-escalation, phase I clinical trial
by: Saeed Oraee-Yazdani, et al.
Published: (2023-05-01) -
Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies
by: Adriana Bajetto, et al.
Published: (2020-11-01) -
Cell motility and migration as determinants of stem cell efficacy
by: Lusine Danielyan, et al.
Published: (2020-10-01) -
Different Effects of Human Umbilical Cord Mesenchymal Stem Cells on Glioblastoma Stem Cells by Direct Cell Interaction or Via Released Soluble Factors
by: Adriana Bajetto, et al.
Published: (2017-10-01) -
Transcriptomic analysis of neural stem and progenitor cells in comparison with glioblastoma stem cells
by: V. E. Shevchenko, et al.
Published: (2023-12-01)